Marex (MRX) EBITDA (2023 - 2026)

Marex (MRX) has reported EBITDA for 4 consecutive years, with -$105.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 566.52% year-over-year to -$105.9 million; the trailing twelve-month figure through Jun 2026 stood at -$387.4 million (down 153.63% YoY), and the FY2025 full-year result was -$348.6 million, down 43.87% from the prior year.
• EBITDA slipped to -$105.9 million in Q2 2026 per MRX's latest filing, from -$63.7 million in the prior quarter.
• Across five years, EBITDA topped out at $388.4 million in Q1 2025 and bottomed at -$117.5 million in Q4 2025.
• Historically, EBITDA has averaged $43.2 million across 4 years, with a median of $22.7 million in 2025.
• The sharpest annual moves came in 2024 and 2026: EBITDA soared 1308.38% in 2024, then tumbled 566.52% in 2026.
• Over 4 years, EBITDA stood at -$19.1 million in 2023, then jumped by 1308.38% to $230.8 million in 2024, then tumbled by 150.91% to -$117.5 million in 2025, then rose by 9.87% to -$105.9 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$105.9 million, -$63.7 million, and -$117.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.